ÂÜÀòÂÒÂ×

Kimberlee Caple has served as a member of the board of directors since July 2021. Since mid-2020, Ms. Caple has served as Vice President and General Manager, Genetic Science Business, at Thermo Fisher Scientific. The Genetic Science Business is made up of three business units that develop, manufacture, and commercialize genetic analysis technologies that serve the healthcare, forensic, research, and pharmaceutical/biotechnology markets globally. From 2017 through mid-2020, Ms. Caple was Vice President and General Manager for the capillary electrophoresis business unit, a part of the Genetic Science Business within Thermo Fisher Scientific. From 2015 through 2016, she was Vice President of Clinical Business at Affymetrix, responsible for microarray products serving the reproductive health and oncology clinical laboratory markets. Affymetrix was acquired by Thermo Fisher Scientific in 2016. Ms. Caple supported the integration of the Affymetrix business into a new microarray business unit within the Genetic Science Business of Thermo Fisher Scientific. Ms. Caple holds a B.S. degree in Biology from Purdue University.